You are here

Drug Forecast

Gefitinib: The First in a New Class of Agents for Non-Small Cell Lung Cancer

Charnelda G. Ruffin, PharmD, and Kathryn L. Harris, PharmD, MSHCM
PDF version: 
Drs. Ruffin and Harris review gefitinib (Iressa™), a new agent for the treatment of non-small cell lung cancer.